Report cover image

Global DTIs for Injection Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 114 Pages
SKU # APRC20339766

Description

Summary

According to APO Research, The global DTIs for Injection market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for DTIs for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for DTIs for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for DTIs for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of DTIs for Injection include Yangtze River Pharmaceutical, Beijing SL Pharmaceutical, CSPC Ouyi Pharmaceutical, Lunan Pharmaceutical, BrightGene, The Medicines Company, Teva Pharmaceutical, Sandoz and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DTIs for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DTIs for Injection.
The DTIs for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DTIs for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

DTIs for Injection Segment by Company

Yangtze River Pharmaceutical
Beijing SL Pharmaceutical
CSPC Ouyi Pharmaceutical
Lunan Pharmaceutical
BrightGene
The Medicines Company
Teva Pharmaceutical
Sandoz
Pfizer
Mitsubishi Tanabe Pharma
GlaxoSmithKline
Eugia Pharma
Dr.Reddy's Laboratories
Aurobindo Pharma
Apotex
Accord Healthcare
DTIs for Injection Segment by Type

Argatroban
Bivalirudin
Other
DTIs for Injection Segment by Application

Pulmonary Embolism
Deep Vein Thrombosis
Atrial Fibrillation
Other
DTIs for Injection Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DTIs for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DTIs for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DTIs for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DTIs for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of DTIs for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

114 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global DTIs for Injection Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global DTIs for Injection Sales Estimates and Forecasts (2020-2031)
1.3 DTIs for Injection Market by Type
1.3.1 Argatroban
1.3.2 Bivalirudin
1.3.3 Other
1.4 Global DTIs for Injection Market Size by Type
1.4.1 Global DTIs for Injection Market Size Overview by Type (2020-2031)
1.4.2 Global DTIs for Injection Historic Market Size Review by Type (2020-2025)
1.4.3 Global DTIs for Injection Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America DTIs for Injection Sales Breakdown by Type (2020-2025)
1.5.2 Europe DTIs for Injection Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific DTIs for Injection Sales Breakdown by Type (2020-2025)
1.5.4 South America DTIs for Injection Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa DTIs for Injection Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 DTIs for Injection Industry Trends
2.2 DTIs for Injection Industry Drivers
2.3 DTIs for Injection Industry Opportunities and Challenges
2.4 DTIs for Injection Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by DTIs for Injection Revenue (2020-2025)
3.2 Global Top Players by DTIs for Injection Sales (2020-2025)
3.3 Global Top Players by DTIs for Injection Price (2020-2025)
3.4 Global DTIs for Injection Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global DTIs for Injection Major Company Production Sites & Headquarters
3.6 Global DTIs for Injection Company, Product Type & Application
3.7 Global DTIs for Injection Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global DTIs for Injection Market CR5 and HHI
3.8.2 Global Top 5 and 10 DTIs for Injection Players Market Share by Revenue in 2024
3.8.3 2023 DTIs for Injection Tier 1, Tier 2, and Tier 3
4 DTIs for Injection Regional Status and Outlook
4.1 Global DTIs for Injection Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global DTIs for Injection Historic Market Size by Region
4.2.1 Global DTIs for Injection Sales in Volume by Region (2020-2025)
4.2.2 Global DTIs for Injection Sales in Value by Region (2020-2025)
4.2.3 Global DTIs for Injection Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global DTIs for Injection Forecasted Market Size by Region
4.3.1 Global DTIs for Injection Sales in Volume by Region (2026-2031)
4.3.2 Global DTIs for Injection Sales in Value by Region (2026-2031)
4.3.3 Global DTIs for Injection Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 DTIs for Injection by Application
5.1 DTIs for Injection Market by Application
5.1.1 Pulmonary Embolism
5.1.2 Deep Vein Thrombosis
5.1.3 Atrial Fibrillation
5.1.4 Other
5.2 Global DTIs for Injection Market Size by Application
5.2.1 Global DTIs for Injection Market Size Overview by Application (2020-2031)
5.2.2 Global DTIs for Injection Historic Market Size Review by Application (2020-2025)
5.2.3 Global DTIs for Injection Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America DTIs for Injection Sales Breakdown by Application (2020-2025)
5.3.2 Europe DTIs for Injection Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific DTIs for Injection Sales Breakdown by Application (2020-2025)
5.3.4 South America DTIs for Injection Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa DTIs for Injection Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Yangtze River Pharmaceutical
6.1.1 Yangtze River Pharmaceutical Comapny Information
6.1.2 Yangtze River Pharmaceutical Business Overview
6.1.3 Yangtze River Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Yangtze River Pharmaceutical DTIs for Injection Product Portfolio
6.1.5 Yangtze River Pharmaceutical Recent Developments
6.2 Beijing SL Pharmaceutical
6.2.1 Beijing SL Pharmaceutical Comapny Information
6.2.2 Beijing SL Pharmaceutical Business Overview
6.2.3 Beijing SL Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Beijing SL Pharmaceutical DTIs for Injection Product Portfolio
6.2.5 Beijing SL Pharmaceutical Recent Developments
6.3 CSPC Ouyi Pharmaceutical
6.3.1 CSPC Ouyi Pharmaceutical Comapny Information
6.3.2 CSPC Ouyi Pharmaceutical Business Overview
6.3.3 CSPC Ouyi Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSPC Ouyi Pharmaceutical DTIs for Injection Product Portfolio
6.3.5 CSPC Ouyi Pharmaceutical Recent Developments
6.4 Lunan Pharmaceutical
6.4.1 Lunan Pharmaceutical Comapny Information
6.4.2 Lunan Pharmaceutical Business Overview
6.4.3 Lunan Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lunan Pharmaceutical DTIs for Injection Product Portfolio
6.4.5 Lunan Pharmaceutical Recent Developments
6.5 BrightGene
6.5.1 BrightGene Comapny Information
6.5.2 BrightGene Business Overview
6.5.3 BrightGene DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BrightGene DTIs for Injection Product Portfolio
6.5.5 BrightGene Recent Developments
6.6 The Medicines Company
6.6.1 The Medicines Company Comapny Information
6.6.2 The Medicines Company Business Overview
6.6.3 The Medicines Company DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The Medicines Company DTIs for Injection Product Portfolio
6.6.5 The Medicines Company Recent Developments
6.7 Teva Pharmaceutical
6.7.1 Teva Pharmaceutical Comapny Information
6.7.2 Teva Pharmaceutical Business Overview
6.7.3 Teva Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceutical DTIs for Injection Product Portfolio
6.7.5 Teva Pharmaceutical Recent Developments
6.8 Sandoz
6.8.1 Sandoz Comapny Information
6.8.2 Sandoz Business Overview
6.8.3 Sandoz DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sandoz DTIs for Injection Product Portfolio
6.8.5 Sandoz Recent Developments
6.9 Pfizer
6.9.1 Pfizer Comapny Information
6.9.2 Pfizer Business Overview
6.9.3 Pfizer DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer DTIs for Injection Product Portfolio
6.9.5 Pfizer Recent Developments
6.10 Mitsubishi Tanabe Pharma
6.10.1 Mitsubishi Tanabe Pharma Comapny Information
6.10.2 Mitsubishi Tanabe Pharma Business Overview
6.10.3 Mitsubishi Tanabe Pharma DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mitsubishi Tanabe Pharma DTIs for Injection Product Portfolio
6.10.5 Mitsubishi Tanabe Pharma Recent Developments
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Comapny Information
6.11.2 GlaxoSmithKline Business Overview
6.11.3 GlaxoSmithKline DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GlaxoSmithKline DTIs for Injection Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments
6.12 Eugia Pharma
6.12.1 Eugia Pharma Comapny Information
6.12.2 Eugia Pharma Business Overview
6.12.3 Eugia Pharma DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eugia Pharma DTIs for Injection Product Portfolio
6.12.5 Eugia Pharma Recent Developments
6.13 Dr.Reddy's Laboratories
6.13.1 Dr.Reddy's Laboratories Comapny Information
6.13.2 Dr.Reddy's Laboratories Business Overview
6.13.3 Dr.Reddy's Laboratories DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dr.Reddy's Laboratories DTIs for Injection Product Portfolio
6.13.5 Dr.Reddy's Laboratories Recent Developments
6.14 Aurobindo Pharma
6.14.1 Aurobindo Pharma Comapny Information
6.14.2 Aurobindo Pharma Business Overview
6.14.3 Aurobindo Pharma DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Aurobindo Pharma DTIs for Injection Product Portfolio
6.14.5 Aurobindo Pharma Recent Developments
6.15 Apotex
6.15.1 Apotex Comapny Information
6.15.2 Apotex Business Overview
6.15.3 Apotex DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Apotex DTIs for Injection Product Portfolio
6.15.5 Apotex Recent Developments
6.16 Accord Healthcare
6.16.1 Accord Healthcare Comapny Information
6.16.2 Accord Healthcare Business Overview
6.16.3 Accord Healthcare DTIs for Injection Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Accord Healthcare DTIs for Injection Product Portfolio
6.16.5 Accord Healthcare Recent Developments
7 North America by Country
7.1 North America DTIs for Injection Sales by Country
7.1.1 North America DTIs for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America DTIs for Injection Sales by Country (2020-2025)
7.1.3 North America DTIs for Injection Sales Forecast by Country (2026-2031)
7.2 North America DTIs for Injection Market Size by Country
7.2.1 North America DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America DTIs for Injection Market Size by Country (2020-2025)
7.2.3 North America DTIs for Injection Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe DTIs for Injection Sales by Country
8.1.1 Europe DTIs for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe DTIs for Injection Sales by Country (2020-2025)
8.1.3 Europe DTIs for Injection Sales Forecast by Country (2026-2031)
8.2 Europe DTIs for Injection Market Size by Country
8.2.1 Europe DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe DTIs for Injection Market Size by Country (2020-2025)
8.2.3 Europe DTIs for Injection Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific DTIs for Injection Sales by Country
9.1.1 Asia-Pacific DTIs for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific DTIs for Injection Sales by Country (2020-2025)
9.1.3 Asia-Pacific DTIs for Injection Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific DTIs for Injection Market Size by Country
9.2.1 Asia-Pacific DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific DTIs for Injection Market Size by Country (2020-2025)
9.2.3 Asia-Pacific DTIs for Injection Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America DTIs for Injection Sales by Country
10.1.1 South America DTIs for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America DTIs for Injection Sales by Country (2020-2025)
10.1.3 South America DTIs for Injection Sales Forecast by Country (2026-2031)
10.2 South America DTIs for Injection Market Size by Country
10.2.1 South America DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America DTIs for Injection Market Size by Country (2020-2025)
10.2.3 South America DTIs for Injection Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa DTIs for Injection Sales by Country
11.1.1 Middle East and Africa DTIs for Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa DTIs for Injection Sales by Country (2020-2025)
11.1.3 Middle East and Africa DTIs for Injection Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa DTIs for Injection Market Size by Country
11.2.1 Middle East and Africa DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa DTIs for Injection Market Size by Country (2020-2025)
11.2.3 Middle East and Africa DTIs for Injection Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 DTIs for Injection Value Chain Analysis
12.1.1 DTIs for Injection Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 DTIs for Injection Production Mode & Process
12.2 DTIs for Injection Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 DTIs for Injection Distributors
12.2.3 DTIs for Injection Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.